CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00079-07v1
14/9/1138    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voltan, S.
Right arrow Articles by Martines, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voltan, S.
Right arrow Articles by Martines, D.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, September 2007, p. 1138-1148, Vol. 14, No. 9
1071-412X/07/$08.00+0     doi:10.1128/CVI.00079-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Aggregating Phenotype in Lactobacillus crispatus Determines Intestinal Colonization and TLR2 and TLR4 Modulation in Murine Colonic Mucosa{triangledown}

Sandra Voltan,1 Ignazio Castagliuolo,1* Marina Elli,4 Stefano Longo,4 Paola Brun,1 Renata D'Incà,2 Andrea Porzionato,3 Veronica Macchi,3 Giorgio Palù,1 Giacomo C. Sturniolo,2 Lorenzo Morelli,4 and Diego Martines2

Department of Histology, Microbiology, and Medical Biotechnologies,1 Department of Gastroenterological Sciences,2 Department of Human Anatomy and Physiology, University of Padua, Padua, Italy,3 AAT-Advanced Analytical Technologies S.r.l., Piacenza, Italy4

Received 5 February 2007/ Returned for modification 18 April 2007/ Accepted 5 July 2007

The colonic microbiota is a major modulator of the mucosal immune system; therefore, its manipulation through supplementation with probiotics may significantly affect the host's immune responses. Since different probiotics seem to exert various effects in vivo, we tested the relevance of the autoaggregation phenotype on the intestinal persistence of lactobacilli and their ability to modulate the host's innate immune responses. After 14 days of diet supplementation, the aggregating strain Lactobacillus crispatus M247 but not aggregation-deficient isogenic mutant MU5 was recovered from the feces and colonic mucosa of mice. This observation was confirmed by strain-specific PCR amplification and by Lactobacillus-specific denaturing gradient gel electrophoresis analysis. Indeed, L. crispatus M247 increased Toll-like receptor 2 (TLR2) mRNA levels, while it reduced TLR4 mRNA and protein levels in the colonic mucosa, whereas MU5 was ineffective. In colonic epithelial cells (CMT-93 cells) L. crispatus M247 but not MU5 induced time-dependent extracellular signal-regulated kinase-1 (ERK1) tyrosine phosphorylation and TLR modulation, which were abolished in the presence of PD98059 (an ERK1 inhibitor). To assess the functional relevance of probiotic-induced TLR modulation, we determined the consequences of L. crispatus preexposure on TLR4 (lipopolysaccharide [LPS]) and TLR2 [Pam3Cys-Ser-(Lys)4] ligand-mediated effects in intestinal epithelial cells. Preexposure to L. crispatus M247 blunted LPS-induced interleukin-6 (IL-6) release and inhibition of CMT-93 migration over a wound edge, whereas it enhanced TLR2-mediated IL-10 up-regulation. In summary, the aggregation phenotype is required for L. crispatus persistence in the colon and for modulation of TLR2/TLR4 expression through an ERK-dependent pathway. We speculate that the aggregation phenotype in L. crispatus M247 is required to temper epithelial cell responsiveness to bacterial endotoxins, which thus affects the evolution of intestinal inflammatory processes.


* Corresponding author. Mailing address: University of Padua, School of Pharmacy, Department of Histology, Microbiology, and Medical Biotechnologies, Via A. Gabelli 63, Padua 35121, Italy. Phone: 049-827-2360. Fax: 049-827-2355. E-mail: ignazio.castagliuolo{at}unipd.it

{triangledown} Published ahead of print on 18 July 2007.


Clinical and Vaccine Immunology, September 2007, p. 1138-1148, Vol. 14, No. 9
1071-412X/07/$08.00+0     doi:10.1128/CVI.00079-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.